NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
Receive an email update when we add a new INFLAMMATION article.
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- IBD therapy horizon consists of new agents, improved applications on December 13, 2018 at 11:31 am
ORLANDO — Brian G. Feagan, MD, FACG, from the Robarts Research Institute at the University of Western Ontario, discussed current anti-TNF therapy options for inflammatory bowel disease and the need fo... […]
- Stem Cell Therapy: Joint Pain Relief… Naturally on December 3, 2018 at 8:06 am
Stem Cell Therapy is revolutionizing the health care industry by offering a way for patients to avoid the risks and long recovery times associated with surgery and pain medication. Stem cells have the ... […]
- NIH scientists identify natural lipid acting as potent anti-inflammatory therapy on July 9, 2018 at 4:52 am
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance ... […]
- New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy ‘as needed’ in mild asthma on May 17, 2018 at 7:25 am
3,4 The SYGMA trials were designed to evaluate the efficacy of Symbicort Turbuhaler, taken only as needed, as an anti-inflammatory reliever versus current standard of care therapies in mild asthma: In ... […]
- Araim's Cibinetide in Inflammatory and Autoimmune Diseases: Increasing Evidence for Immune Modulation and Pleiotropic Benefit on May 15, 2018 at 10:05 pm
Treatments aimed at suppressing inflammatory activity include corticosteroids, which have frequent side effects, and more recently, biologics such as anti-TNF therapies. However, approximately 30% of ... […]
- A common anti-inflammatory therapy may help reduce risk of developing Parkinson's disease on April 23, 2018 at 8:02 am
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia A recent study from researchers ... […]
- Level of inflammation could help predict effectiveness of electroconvulsive therapy for major depression on March 6, 2018 at 6:53 am
People with major depression that has not been well controlled by medications and who have a biomarker in their blood indicating a higher level of inflammation may benefit more than people with less i... […]
- Level of inflammation could help predict effectiveness of electroconvulsive therapy for major depression on March 5, 2018 at 9:50 am
Interleukin 6 is one of the inflammatory molecules in the blood associated with depression. People with major depression that has not been well controlled by medications and who have a biomarker in th... […]
- Anti-inflammatory therapy cuts risk of lung cancer on August 28, 2017 at 7:58 am
In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique oppor... […]
via Bing News